BGI EUROPE A/S: Financial statements 2014
CVR: 32931340
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
BGI EUROPE A/S (CVR 32931340) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 15,977,943 and a net result of DKK 935,425 compared with DKK 1,095,829 the year before. That is an increase of 16.7% compared with the year before. Equity in the 2014 report amounted to DKK 25,255,090. The solvency ratio was 37.3%.
- Gross Profit
- DKK 15,977,943
- Profit/Loss
- DKK 935,425
- Equity
- DKK 25,255,090
- Total Assets
- DKK 67,756,585
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 16M | 935K | 25.3M | - |
| 2013 | - | 13.7M | 1.1M | 24.3M | - |
| 2012 | - | 11.3M | 800K | 6.3M | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
BGI EUROPE A/S has published its annual report for 2013. Gross profit came to DKK 13,697,165, and the net result was DKK 1,095,829.
About BGI EUROPE A/S
BGI EUROPE A/S is a Danish company of the type Aktieselskab based in Herlev, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of JUN CHENG. The board consists of Ning Li (chair), CAO Sujie, Hao Zeng and JUN CHENG. The company is owned by BGI Genomics Co., Ltd.. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK -5,028,063 and a net result of DKK -32,211,033 compared with DKK -15,695,243 the year before. Equity in the 2025 report amounted to DKK -1,950,676.